Literature DB >> 19778071

The second-generation anticancer drug Nedaplatin: a theoretical investigation on the hydrolysis mechanism.

Marta E Alberto1, Maria Fatima A Lucas, Matej Pavelka, Nino Russo.   

Abstract

The hydrolysis reaction processes of the second-generation platinum derivative Nedaplatin have been studied using density functional theory (DFT) combined with the conductor-like dielectric continuum model (CPCM) approach, in order to obtain detailed data on its mechanism of action. The first and the second hydrolysis of Nedaplatin, corresponding to the ring opening followed by the loss of the ligand, respectively, have been explored in neutral and acid conditions. The influence of an extra water molecule which could assist the degradation processes has also been considered including in our models an explicit water molecule other than the reactive one. The computed potential energy surfaces show that the rate limiting step in neutral conditions is the first hydrolysis process and, consequently, the double hydrated complex is suggested to be the species reacting with the DNA purine bases, while in acid conditions the trend is different, with the second hydrolysis process being the rate limiting step. The results obtained in this work allow us to make a comparison with the trends previously found for the other platinum anticancer drugs currently used in the medical protocols.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19778071     DOI: 10.1021/jp9056835

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  8 in total

1.  Atomic level rendering of DNA-drug encounter.

Authors:  Maria F Lucas; Israel Cabeza de Vaca; Ryoji Takahashi; Jaime Rubio-Martínez; Víctor Guallar
Journal:  Biophys J       Date:  2014-01-21       Impact factor: 4.033

2.  Iodide Analogs of Arsenoplatins-Potential Drug Candidates for Triple Negative Breast Cancers.

Authors:  Ðenana Miodragović; Wenan Qiang; Zohra Sattar Waxali; Željko Vitnik; Vesna Vitnik; Yi Yang; Annie Farrell; Matthew Martin; Justin Ren; Thomas V O'Halloran
Journal:  Molecules       Date:  2021-09-06       Impact factor: 4.927

3.  Phase II Study of a Bi-Weekly Chemotherapy Regimen of Combined Liposomal Paclitaxel and Nedaplatin for the Treatment of Advanced Squamous Cell Lung Cancer.

Authors:  Wei-Ze Lv; Zhong Lin; Si-Yang Wang; Bao-Jun Lv; Zhi-Hui Wang; Mei Xiao; Xiao-Lu Xu; Pei-Jian Peng
Journal:  Transl Oncol       Date:  2019-02-27       Impact factor: 4.243

4.  Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial.

Authors:  Qing-Nan Tang; Li-Ting Liu; Bin Qi; Shan-Shan Guo; Dong-Hua Luo; Rui Sun; Xue-Song Sun; Dong-Ping Chen; Ling Guo; Hao-Yuan Mo; Pan Wang; Sai-Lan Liu; Yu-Jing Liang; Xiao-Yun Li; Zhen-Chong Yang; Qiu-Yan Chen; Hai-Qiang Mai; Lin-Quan Tang
Journal:  JAMA Netw Open       Date:  2021-12-01

5.  Synthesis, Characterization, Thermal Analysis, DFT, and Cytotoxicity of Palladium Complexes with Nitrogen-Donor Ligands.

Authors:  Sattar R Majeed; Mina A Amin; Fawzy A Attaby; Marta E Alberto; Ahmed A Soliman
Journal:  Molecules       Date:  2022-01-31       Impact factor: 4.411

6.  Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.

Authors:  Zhongyu Liu; Jun Liu; Li Li; Dan Nie; Qilei Tao; Jian Wu; Jiajun Fan; Chen Lin; Shuwei Zhao; Dianwen Ju
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

Review 7.  Advances in drug delivery system for platinum agents based combination therapy.

Authors:  Xiang Kang; Hai-Hua Xiao; Hai-Qin Song; Xia-Bin Jing; Le-San Yan; Ruo-Gu Qi
Journal:  Cancer Biol Med       Date:  2015-12       Impact factor: 4.248

8.  Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database.

Authors:  Misa Naganuma; Yumi Motooka; Sayaka Sasaoka; Haruna Hatahira; Shiori Hasegawa; Akiho Fukuda; Satoshi Nakao; Kazuyo Shimada; Koseki Hirade; Takayuki Mori; Tomoaki Yoshimura; Takeshi Kato; Mitsuhiro Nakamura
Journal:  SAGE Open Med       Date:  2018-04-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.